Periodic fever in MVK deficiency: A patient initially diagnosed with incomplete Kawasaki disease

Pediatrics

Volumn 133, Issue 2, 2014, Pages

  Thors, Valtyr S ^a   Vastert, Sebastiaan J ^a   Wulffraat, Nico ^a   Van Royen, Annet ^a   Frenkel, Joost ^a   De Sain Van Der Velden, Monique ^a   De Koning, Tom J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Auto inflammatory disease; Fever of unknown origin; Hyperimmunoglobulin D syndrome (HIDS); Kawasaki syndrome; Mevalonate kinase; Mevalonic acid

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; MEVALONATE KINASE; MEVALONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; CASE REPORT; CLINICAL FEATURE; CONSCIOUSNESS; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INFANT; MEVALONATE KINASE DEFICIENCY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUTATIONAL ANALYSIS; MVK GENE; OMPHALITIS; PHENOTYPE; PRIORITY JOURNAL; RECURRENT FEVER; URINARY EXCRETION;

AUTO INFLAMMATORY DISEASE; FEVER OF UNKNOWN ORIGIN; HYPERIMMUNOGLOBULIN D SYNDROME (HIDS); KAWASAKI SYNDROME; MEVALONATE KINASE; MEVALONIC ACID;

DIAGNOSTIC ERRORS; FEMALE; HUMANS; INFANT; MEVALONATE KINASE DEFICIENCY; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 84893328749     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-1372     Document Type: Article

References (25)

1. Houten SM, Kuis W, Duran M, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet. 1999; 22(2):175-177
2. Drenth JP, Cuisset L, Grateau G, et al; International Hyper-IgD Study Group. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet. 1999;22(2):178-181
3. Haas D, Hoffmann GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006;1:13
4. Drenth JP, Haagsma CJ, van der Meer JW; International Hyper-IgD Study Group. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. Medicine (Baltimore). 1994;73(3):133-144
5. Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med. 2001;345(24): 1748-1757
6. van der Meer JW, Vossen JM, Radl J, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984;1 (8386):1087-1090
7. Frenkel J, Houten SM, Waterham HR, et al. Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatology (Oxford). 2001;40(5):579-584
8. Simon A, Bijzet J, Voorbij HA, Mantovani A, van der Meer JW, Drenth JP. Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response. J Intern Med. 2004;256(3): 247-253
9. van der Hilst JC, Bodar EJ, Barron KS, et al; International HIDS Study Group. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008;87(6):301-310
10. Newburger JW, Takahashi M, Gerber MA, et al; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708-1733
11. Yeo Y, Kim T, Ha K, et al. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr. 2009;168(2):157-162
12. Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J. 2006;25(3):241-244
13. Saulsbury FT. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome. Clin Pediatr (Phila). 2002;41(8):597-601
14. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315(6):341-347
15. Newburger JW, Takahashi M, Gerber MA, et al; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747-2771
16. Bratincsak A, Reddy VD, Purohit PJ, et al. Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with fever. Pediatr Infect Dis J. 2012;31(9): 924-926
17. Mavrogeni S, Manoussakis MN, Karagiorga TC, et al. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum. 2009;61(8):1121-1129
18. Kumar S, Vaidyanathan B, Gayathri S, Rajam L. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. Rheumatol Int. 2013;33(4):1065-1069
19. Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med. 2005;63(7):260-264
20. Topaloǧlu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sanal O. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol. 2008;27(10):1317-1320
21. Simon A, Drewe E, van der Meer JW, et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther. 2004;75(5):476-483
22. Prietsch V, Mayatepek E, Krastel H, et al. Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics. 2003;111(2):258-261
23. Ammouri W, Cuisset L, Rouaghe S, et al. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford). 2007;46(10):1597-1600
24. McCrindle BW, Li JS, Minich LL, et al; Pediatric Heart Network Investigators. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116(2):174-179
25. Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr. 2011;24(1):60-74